↓ Skip to main content

Cochrane Database of Systematic Reviews

Metformin monotherapy for type 2 diabetes mellitus

Overview of attention for article published in this source, July 2005
Altmetric Badge

Mentioned by

policy
2 policy sources
twitter
2 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
275 Dimensions

Readers on

mendeley
208 Mendeley
citeulike
4 CiteULike
Title
Metformin monotherapy for type 2 diabetes mellitus
Published by
John Wiley & Sons, Ltd, July 2005
DOI 10.1002/14651858.cd002966.pub3
Pubmed ID
Authors

Saenz, Antonio, Fernandez-Esteban, Inmaculada, Mataix, Angel, Ausejo Segura, Monica, Roqué i Figuls, Marta, Moher, David

Abstract

Metformin is an anti-hyperglycaemic agent used for the treatment of type 2 diabetes mellitus. Type 2 diabetes may present long-term complications: micro- (retinopathy, nephropathy and neuropathy) and macrovascular (stroke, myocardial infarction and peripheral vascular disease). Two meta-analyses have been published before, although only secondary outcomes were assessed.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 3 1%
Brazil 3 1%
Italy 2 <1%
United States 2 <1%
Denmark 1 <1%
Ireland 1 <1%
Unknown 196 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 35 17%
Student > Bachelor 33 16%
Researcher 27 13%
Student > Ph. D. Student 23 11%
Other 17 8%
Other 41 20%
Unknown 32 15%
Readers by discipline Count As %
Medicine and Dentistry 116 56%
Agricultural and Biological Sciences 17 8%
Nursing and Health Professions 9 4%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Biochemistry, Genetics and Molecular Biology 4 2%
Other 13 6%
Unknown 41 20%